RxDoctor Payments DataLook up a doctor →

Kenneth Blaze

Internal Medicine · Pembroke Pines, FLNPI 1295761286

Payments from drug & device makers

$4,282,088in general payments, 2019–2025

Across 1,704 payments — averaging $2512.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2.1M
  • Novo Nordisk AS$717K
  • Alnylam Pharmaceuticals Inc.$683K
  • Endo Pharmaceuticals Inc.$541K
  • Esperion Therapeutics, Inc.$58K
  • AbbVie$54K
  • plus $87K from 18 others
$62,296in research payments, 2019–2025

Across 7 payments — averaging $8899.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$62K

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,282,088 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Other internal medicine in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →